Pulse Biosciences Quarterly Investor Conference Call
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on tech boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil prices rise on Trump timeline for Iran peace deal: after US elections
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Pulse Biosciences, Inc. (PLSE) Reports Q3 Loss of $0.64
October 30, 2018 4:40 PM EDTPulse Biosciences, Inc. (NASDAQ: PLSE) reported Q3 EPS of ($0.64).
Were pleased with the continued and significant progress weve made and are making towards bringing our NPS platform closer to commercialization, said Darrin Uecker, Pulse Biosciences President and Chief Executive Officer. Our data... More
